IMO, this PR is what much of the recent speculative money is responding to. They are drawing lines from Keytruda and it's growing success re FDA acceptance, to AE37 and it's possible success WRT Keytruda down the road. Anyone interested in investing in that possibility would be crazy to not take the opportunity to multiply that potential success by 20.